NCT06812832View on ClinicalTrials.gov

Simethicone as Part of ERAS in Bariatric Surgery Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

April 8, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2029

Conditions
SimethiconeBariatric SurgeryPost-operative Pain
Interventions
DRUG

Simethicone 80 MG

Patients will receive simethicone 80mg four times per day for 2 weeks post-operatively.

DRUG

Placebo

Patients in the control group will receive a placebo pill four times per day for 2 weeks

Trial Locations (1)

98431

RECRUITING

Madigan Army Medical Center, Tacoma

All Listed Sponsors
lead

Madigan Army Medical Center

FED